Literature DB >> 11368471

Mechanisms of diabetic vasculopathy: an overview.

M E Cooper1, F Bonnet, M Oldfield, K Jandeleit-Dahm.   

Abstract

Diabetes is commonly associated with both microvascular and macrovascular complications. These vascular complications are accelerated in the context of systemic hypertension. During the past few years the underlying molecular mechanisms responsible for diabetic vascular complications have begun to be clarified. It appears that both metabolic and hemodynamic factors interact to stimulate the expression of cytokines and growth factors in the various vascular trees. Overexpression of the prosclerotic cytokine transforming growth factor-beta has been observed in glomeruli and tubules from the diabetic kidney. In the retina the angiogenic cytokine vascular endothelial growth factor and its receptor, vascular endothelial growth factor R-2 are increased in experimental diabetes. These changes in growth factors are viewed to be responsible for the extracellular matrix accumulation in the diabetic kidney and new vessel formation in the diabetic retina. Changes in cytokines have also been observed at other vascular sites including the mesenteric vascular tree. Vasoactive hormones, such as angiotensin II and endothelin, are potent stimulators of cytokines with recent studies showing that inhibitors of these vasoactive hormone pathways may confer organ protection in diabetes by inhibition of growth factor expression. Glucose-dependent factors, such as the formation of advanced glycation end products that interact with specific receptors and lead to overexpression of a range of cytokines, may play an important role in diabetic vascular complications including atherosclerosis. It is likely that the effects of inhibitors of this pathway such as aminoguanidine on cytokine production may play a pivotal role in mediating the renal, retinal, and vasoprotective effects observed with this agent in experimental diabetes. It is anticipated that the advent of specific inhibitors of cytokine formation or action will provide new approaches for the prevention and treatment of diabetic vascular complications.

Entities:  

Mesh:

Year:  2001        PMID: 11368471     DOI: 10.1016/s0895-7061(00)01323-6

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  56 in total

Review 1.  The endothelium: physiological functions and role in microcirculatory failure during severe sepsis.

Authors:  H Ait-Oufella; E Maury; S Lehoux; B Guidet; G Offenstadt
Journal:  Intensive Care Med       Date:  2010-05-05       Impact factor: 17.440

Review 2.  The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.

Authors:  Stephen P Gray; Karin Jandeleit-Dahm
Journal:  J Mol Med (Berl)       Date:  2014-04-01       Impact factor: 4.599

Review 3.  Canonical transient receptor potential channels in diabetes.

Authors:  Sarabeth Graham; Joseph P Yuan; Rong Ma
Journal:  Exp Biol Med (Maywood)       Date:  2012-01-26

4.  Monitoring of cardiovascular reactivity to cold stress using digital volume pulse characteristics in health and diabetes.

Authors:  Ashok K Jaryal; Nandakumar Selvaraj; Jayashree Santhosh; Sneh Anand; Kishore K Deepak
Journal:  J Clin Monit Comput       Date:  2009-03-24       Impact factor: 2.502

5.  Elevated fibroblast growth factor-2 increases tumor necrosis factor-alpha induced endothelial cell death in high glucose.

Authors:  Alisa Morss Clyne; Han Zhu; Elazer R Edelman
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

6.  Inhibition of Porcine Pancreatic Amylase Activity by Sulfamethoxazole: Structural and Functional Aspect.

Authors:  Sujan Maity; Koel Mukherjee; Amrita Banerjee; Suman Mukherjee; Dipak Dasgupta; Suvroma Gupta
Journal:  Protein J       Date:  2016-06       Impact factor: 2.371

Review 7.  Endoplasmic-reticulum calcium depletion and disease.

Authors:  Djalila Mekahli; Geert Bultynck; Jan B Parys; Humbert De Smedt; Ludwig Missiaen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

8.  Arsenic-induced decreases in the vascular matrix.

Authors:  Allison M Hays; R Clark Lantz; Laurel S Rodgers; James J Sollome; Richard R Vaillancourt; Angeline S Andrew; Joshua W Hamilton; Todd D Camenisch
Journal:  Toxicol Pathol       Date:  2008-09-23       Impact factor: 1.902

9.  Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats.

Authors:  Xiao Lu; Xiaomei Guo; Sotirios K Karathanasis; Karen M Zimmerman; Jude E Onyia; Richard G Peterson; Ghassan S Kassab
Journal:  Cardiovasc Diabetol       Date:  2010-05-19       Impact factor: 9.951

10.  Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

Authors:  Sayeeda Rahman; Aziz Al-Shafi Ismail; Abdul Rashid A Rahman
Journal:  Int J Diabetes Dev Ctries       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.